Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Quarterly on Schedule

<< Previous

Bullboard Posts

Next >>

Comment by Gorf79on Aug 12, 2022 8:55am

197 Views

Post# 34890879

RE:Quarterly on Schedule

PM,

Your " conviction is that the company is still strong"?

Good to hear.

In the past several week they did this:

1) Landed the largest dialysis provider in Florida as a SAMI client!

2) Received an FDA Breakthrough Designation for their for PMX Sepsis treatment.

3) Landed the U.S. Department of Veterans Affairs as a SAMI client. They are the largest single health network in the United States!

I'd call that "still strong"...

Lets be honest, those would be major accomplishment for a multinational pharma, let alone a minuscule 50 cent company from the West Mall in Etobicoke.

Yeah I'd say they are "still strong"!

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages